| Title |
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
|
|---|---|
| Published in |
ClinicoEconomics and Outcomes Research: CEOR, January 2012
|
| DOI | 10.2147/ceor.s25923 |
| Pubmed ID | |
| Authors |
Alain Vergnenègre, Joshua A Ray, Christos Chouaid, Francesco Grossi, Helge G Bischoff, David F Heigener, Stefan Walzer |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 2 | 6% |
| Unknown | 34 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 28% |
| Other | 7 | 19% |
| Student > Master | 4 | 11% |
| Student > Ph. D. Student | 4 | 11% |
| Student > Doctoral Student | 3 | 8% |
| Other | 5 | 14% |
| Unknown | 3 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 47% |
| Agricultural and Biological Sciences | 4 | 11% |
| Business, Management and Accounting | 3 | 8% |
| Economics, Econometrics and Finance | 3 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 6% |
| Other | 4 | 11% |
| Unknown | 3 | 8% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2019.
All research outputs
#3,654,475
of 25,728,855 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#80
of 527 outputs
Outputs of similar age
#27,692
of 251,729 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#1
of 3 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,729 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them